1. Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. 
Global trends in diabetes complications: A review of current 
evidence. Diabetologia 2019;62:3-16.
2. Fujii H, Kono K, Nishi S. Characteristics of coronary artery 
disease in chronic kidney disease. Clinical and experimental 
nephrology 2019;23:725-32.
3. Ishigami J, Matsushita K. Clinical epidemiology of infectious 
disease among patients with chronic kidney disease. Clin Exp 
Nephrol 2019;23:437-47.
4. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, 
Kasiske BL, et al. Controlling the epidemic of cardiovascular 
disease in chronic renal disease: What do we know? What do 
we need to learn? Where do we go from here? National kidney 
foundation task force on cardiovascular disease. Am J Kidney 
Dis 1998;32:853-906.
5. Bossola M, Di Stasio E, Viola A, Leo A, Carlomagno G, 
Monteburini T, et al. Dietary intake of trace elements, minerals, 
and vitamins of patients on chronic hemodialysis. Int Urol 
Nephrol 2014;46:809-15.
6. Brown KM, Arthur JR. Selenium, selenoproteins and human 
health: A review. Public Health Nutr 2001;4:593-9.
7. Reich HJ, Hondal RJ. Why nature chose selenium. ACS Chem 
Biol 2016;11:821-41.
8. Omrani H, Golmohamadi S, Pasdar Y, Jasemi K, Almasi 
A. Effect of selenium supplementation on lipid profile in 
hemodialysis patients. J Renal Inj Prev. 2016;5:179-82. 
9. Khan MS, Dilawar S, Ali I, Rauf N. The possible role of 
selenium concentration in hepatitis B and C patients. Saudi J 
Gastroenterol 2012;18:106-10.
10. Tóth RJ, Csapó J. The role of selenium in nutrition – A review. 
Acta Univ Sapientiae Aliment 2018;11:128-44.
11. Salehi M, Sohrabi Z, Ekramzadeh M, Fallahzadeh MK, 
Ayatollahi M, Geramizadeh B, et al. Selenium supplementation 
improves the nutritional status of hemodialysis patients: 
A randomized, double-blind, placebo-controlled trial. Nephrol 
Dial Transplant 2013;28:716-23.
12. Zachara BA, Gromadzinska J, Palus J, Zbrog Z, Swiech R, 
Twardowska E, et al. The effect of selenium supplementation 
in the prevention of DNA damage in white blood cells of 
hemodialyzed patients: A pilot study. Biol Trace Elem Res 
2011;142:274-83.
13. Atapour A, Vahdat S, Hosseini M, Mohamadian H. Effect of 
selenium on triglyceride and total cholesterol, weight gain, and 
physical activity on hemodialysis patients: A randomized doubleblinded controlled trial. Int J Prev Med 2022;13:63.
14. Park JH, Jo YI, Lee JH. Renal effects of uric acid: Hyperuricemia 
and hypouricemia. Korean J Intern Med 2020;35:1291-304.
15. Rysz J, Gluba‑Brzózka A, Rysz‑Górzyńska M, Franczyk B. 
The role and function of HDL in patients with chronic kidney 
disease and the risk of cardiovascular disease. Int J Mol Sci 
2020;21:E601.
16. Liu R, Peng Y, Wu H, Diao X, Ye H, Huang X, et al. Uric 
acid to high-density lipoprotein cholesterol ratio predicts 
cardiovascular mortality in patients on peritoneal dialysis. Nutr 
Metab Cardiovasc Dis 2021;31:561-9.
17. Behera AK, Rathor PK, Nahak SR, Marndi C. The Correlation 
Between High-Density Lipoprotein Cholesterol and Glomerular 
Filtration Rate Estimation in a Community-Based Population. 
European Journal of Molecular & Clinical Medicine 
2022;9:3233-42. 
18. Moore C Jr., Ormseth M, Fuchs H. Causes and significance of 
markedly elevated serum ferritin levels in an academic medical 
center. J Clin Rheumatol 2013;19:324-8.
19. Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc 
Nephrol 2012;23:1631-4.
20. Stenvinkel P, Lindholm B. C-reactive protein in end-stage 
renal disease: Are there reasons to measure it? Blood Purif 
2005;23:72-8.
21. Pawlak K, Domaniewski T, Mysliwiec M, Pawlak D. The 
kynurenines are associated with oxidative stress, inflammation 
and the prevalence of cardiovascular disease in patients with 
end-stage renal disease. Atherosclerosis 2009;204:309-14.
22. Li W, Xiong L, Fan L, Wang Y, Peng X, Rong R, et al.
Association of baseline, longitudinal serum high-sensitive 
C-reactive protein and its change with mortality in peritoneal 
dialysis patients. BMC Nephrol 2017;18:211.